We first evaluated blood vessel functionality in ALB-Tag HCC in comparison with PNET in RIP1-Tag5 mice using i.v.-injected lectin binding to blood vessels as a surrogate marker for tumor perfusion. The gene discussed is ALB; the disease is hepatocellular carcinoma.